Skip to content
Research Article Open access CC BY 4.0

Tackling the Burden of Substandard and Falsified Medicines and Health Technologies in Somaliland and Somalia

Saed Nuh Ahmed, Angela Brand

Asian Journal of Medicine and Health · pp. 134–155 · Published 9 Dec 2024

10.9734/ajmah/2024/v22i121144

Abstract

Background: The problem posed by the substandard and falsified (SF) medicines is a rising global challenge. WHO estimates that sales of SF medical products in low- and middle-income countries is around US$ 30 billion whereby 1 in 10 medical is substandard or falsified. Objectives: The purpose of this article was to enlighten the actions by the Somali NRA to tackle the scourge of SF medicines in Somalia. Methods: The literature was reviewed on the topic and evidence from other sources were incorporated including reports of post-marketing surveillance surveys, assessments at national and regional levels, as well as author’s experiences. Findings: The medicines regulatory capacity is weak in Somaliland and Somalia, where only 16% of total indicators for the regulatory system was in place as per WHO/IGAD rapid benchmarking of the National Regulatory Authority (NRA) in 2017, increasing the risk of circulation of SF medicines in the local private sector dominated and exclusively import relied pharmaceutical supply chain. Key actions by the NRA to address this problem include: regulatory reliance mechanisms such as using the WHO PQ/EUL for emergency authorization of vaccines, i.e. COVID-19 vaccines, enhanced licensing procedures, information exchange with NRAs in the region as well as technical collaboration with WHO. Conclusion & Recommendation: However, a lot has to be done and considering the weak laboratory capacity and the porous national borders, the risk of local circulation of SF medicines is high and swift actions are needed to ensure access to safe and quality medicines and health technologies in Somaliland and Somalia.

Substandard and Falsified (SF) medicines WHO Medicines Quality Monitoring (MQM) pharmaceutical supply chain

References (19)

  1. 1 To Err Is Human [DOI]
  2. 2 Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship [DOI]
  3. 3 Potential Causes of Spread of Antimicrobial Resistance and Preventive Measures in One Health Perspective-A Review [DOI]
  4. 4 Impact of poor-quality medicines in the ‘developing’ world [DOI]
  5. 5 Clinical practice guidelines: The good, the bad, and the ugly [DOI]
  6. 6 Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies [DOI]
  7. 7 Prevention of antimicrobial resistance in sub-Saharan Africa: What has worked? What still needs to be done? [DOI]
  8. 8 Monitoring the Quality of Medicines: Results from Africa, Asia, and South America [DOI]
  9. 9 Falsified medicines in Africa: all talk, no action [DOI]
  10. 10 An examination of pharmaceutical systems in severely disrupted countries [DOI]
  11. 11 Rational use of medicines [DOI]
  12. 12 Surveillance for substandard and falsified medicines by local faith-based organizations in 13 low- and middle-income countries using the GPHF Minilab [DOI]
  13. 13 Global Regulations of Medicinal, Pharmaceutical, and Food Products [DOI]
  14. 14 Changes in antimicrobial agent usage resulting from interactions among clinical pharmacy, the infectious disease division, and the microbiology laboratory [DOI]
  15. 15 Assessment of Polypharmacy, Drug Use Patterns, and Associated Factors at the Edna Adan University Hospital, Hargeisa, Somaliland [DOI]
  16. 16 A Qualitative Study on Community Usage of Antibiotics in Mogadishu-Somalia [DOI]
  17. 17 Community Use of Antibiotics in Hargeisa, Somaliland: A Qualitative Study [DOI]
  18. 18 Health systems research on access to medicines: unpacking challenges in implementing policies in the face of the epidemiological transition [DOI]
  19. 19 Mapping and Analysing EdTech initiatives in Latin America and the Caribbean [DOI]

Cited by 6

Medicine quality in Somalia: Strengthening the pharmaceutical supply chain to protect patients

Mohamed Abdirahman Mohamed, Abdukadir Mohamed Hassan · Preventive medicine reports · 2026

Substandard and Falsified Medical Products, Devices, and Online Pharmacy Supply-Chain Security: Scoping Review with ☸️SAIMSARA

· SAIMSARA Journal · 2026

One Health and Antimicrobial resistance in Somalia: Policy Insights from Centennial Vision 2060

S. Hassan, Nur Rashiid Ahmed, Abdifetah Ibrahim Omar · IJID One Health · 2026

Showing 3 of 6 known citations — external sources report more than can currently be individually listed.

Related research

Article metrics

Real usage data collected on this platform.

72

Page views

0

PDF downloads

36

Outbound clicks

6

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.